Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study.
Rigolin GM, Del Giudice I, Bardi A, Melandri A, García-Jacobo RE, Cura F, Raponi S, Ilari C, Cafforio L, Piciocchi A, Arena V, Reda G, Albano F, Molica S, Sportoletti P, Trentin L, Marchetti M, Nanni M, Peragine N, Mariglia P, Vignetti M, Guarini A, Mauro FR, Foà R, Cuneo A.
Rigolin GM, et al.
Blood. 2021 Dec 23;138(25):2727-2730. doi: 10.1182/blood.2021011883.
Blood. 2021.
PMID: 34587233
Free article.
Clinical Trial.
No abstract available.